Clinical Trial Update: Meditoxin® Treatment in Patients With Post Stroke Upper Limb Spasticity [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for Meditoxin treatment in patients with post-stroke upper limb spasticity completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle Spasticity

Drugs mentioned

• Meditoxin (botulinum toxin type A)

Snippet

Sponsor: Medy-Tox | Conditions: Muscle Spasticity | Phase 4 | Status: COMPLETED